EDSA: Edesa Biotech, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.82
Enterprise Value ($M) 4.78
Book Value ($M) 2.87
Book Value / Share 0.88
Price / Book 2.38
NCAV ($M) 0.69
NCAV / Share 0.21
Price / NCAV 9.94

Profitability (mra)
Return on Invested Capital (ROIC) -2.38
Return on Assets (ROA) -0.78
Return on Equity (ROE) -0.98

Liquidity (mrq)
Quick Ratio 1.29
Current Ratio 1.29

Balance Sheet (mrq) ($M)
Current Assets 3.05
Assets 5.23
Liabilities 2.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-01 13D/A Nijhawan Pardeep 19.99 -76.45
06-03 13G Satterfield Thomas A Jr 5.47
01-29 13G/A Velan Capital Investment Management LP 1.97
01-16 13D/A Pardeep Nijhawan Medicine Professional Corp 19.30

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-12-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 1,322 4,306 30.70
2024-11-21 955 13,521 7.06
2024-11-20 2,240 10,485 21.36
2024-11-19 9,734 30,453 31.96
2024-11-18 971 7,186 13.51

(click for more detail)

Similar Companies
DTIL – Precision BioSciences, Inc. DWTX – Dogwood Therapeutics, Inc.
DYAI – Dyadic International, Inc. ELDN – Eledon Pharmaceuticals, Inc.
ELTX – Elicio Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.